Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.49 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | CCNB2 | O95067 | 3/20 | 0.39 |
| ▸ | CDK1 | P06493 | 3/20 | 0.39 |
| ▸ | CDK4 | P11802 | 3/20 | 0.39 |
| ▸ | CCNB1 | P14635 | 3/20 | 0.39 |
| ▸ | CCND1 | P24385 | 3/20 | 0.39 |
| ▸ | CCNB3 | Q8WWL7 | 3/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 4/20 | 0.36 |
| ▸ | PPARD | Q03181 | 3/20 | 0.36 |
| ▸ | PPARG | P37231 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cinnamic Aldehyde SCHEMBL8740777 | 0.93 | ALDH1A1 (0.50) | ALDH1A1LMNATRPA1ALOX5MAPK1 | |
| Cinnamic Aldehyde SCHEMBL5515601 | 0.90 | ALDH1A1 (0.53) | ALDH1A1LMNATRPA1ALOX5MAPK1 | |
| Cinnamic Aldehyde SCHEMBL3159939 | 0.90 | LMNA (0.60) | ALDH1A1LMNATRPA1ALOX5MAPK1 | |
| Benzaldehyde SCHEMBL872657 | 0.86 | ALDH1A1 (0.42) | ALDH1A1LMNANPC1L3MBTL1PPARA | |
| Cinnamaldehyde SCHEMBL2313727 | 0.85 | ALDH1A1 (0.67) | ALDH1A1LMNATRPA1ALOX5MAPK1 | |
| Cinnamaldehyde SCHEMBL2035468 | 0.85 | ALDH1A1 (0.67) | ALDH1A1LMNATRPA1ALOX5MAPK1 | |
| Cinnamaldehyde SCHEMBL1758311 | 0.83 | ALDH1A1 (0.58) | ALDH1A1LMNATRPA1ALOX5MAPK1 | |
| Cinnamic Aldehyde SCHEMBL11702441 | 0.82 | ALDH1A1 (0.44) | ALDH1A1LMNATRPA1ALOX5MAPK1 | |
| Cinnamic Aldehyde SCHEMBL8740823 | 0.82 | ALDH1A1 (0.46) | ALDH1A1LMNATRPA1ALOX5MAPK1 | |
| Benzaldehyde SCHEMBL17698491 | 0.81 | ALDH1A1 (0.38) | ALDH1A1LMNAL3MBTL1PPARAPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1547 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11648298-B2 | Oral care compositions | COLGATE-PALMOLIVE COMPANY (US) | 2023-05-16 | — | — | US | claimed |
| WO-2023046680-A1 | COMBINATION OF CETYLPYRIDINIUM AND BENZYDAMINE WITH VIRUCIDAL EFFECT ON SARS-COV-2 | KRKA, D.D., NOVO MESTO (SI) | 2023-03-30 | — | — | WO | claimed |
| US-20210378920-A1 | WET WIPER ARTICLES AND METHODS FOR CLEANING REMOVABLE DENTAL APPLIANCES | Oral Health Technologies, LLC | 2021-12-09 | — | — | US | claimed |
| US-11185479-B2 | Buffered microencapsulated compositions and methods | PREMIER DENTAL PRODUCTS COMPANY (US) | 2021-11-30 | — | — | US | claimed |
| US-11185480-B2 | Buffered microencapsulated compositions and methods | PREMIER DENTAL PRODUCTS COMPANY (US) | 2021-11-30 | — | — | US | claimed |
| US-20210228691-A1 | Oral Care Compositions | COLGATE-PALMOLIVE COMPANY (US) | 2021-07-29 | — | — | US | claimed |
| EP-3765036-A1 | BUFFERED MICROENCAPSULATED COMPOSITIONS AND METHODS | Premier Dental Products Company (US) | 2021-01-20 | — | — | EP | claimed |
| US-10857075-B2 | Wet wiper articles and methods for cleaning removable dental appliances | Oral Health Technologies, LLC (US) | 2020-12-08 | — | — | US | claimed |
| US-10688026-B2 | Buffered microencapsulated compositions and methods | PREMIER DENTAL PRODUCTS COMPANY (US) | 2020-06-23 | — | — | US | claimed |
| US-10675227-B2 | Buffered microencapsulated compositions and methods | PREMIER DENTAL PRODUCTS COMPANY (US) | 2020-06-09 | — | — | US | claimed |
| EP-0837862-A1 | WARMING COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-29 | — | — | EP | claimed |
| US-5628986-A | TOOTHPASTES, MOUTHRINSES, DENTIFRICES, LOZENGES, GUMS CONTAINING PHOSPHATE DERIVATIVE AND COPPER SOURCE | THE PROCTER & GAMBLE COMPANY (US) | 1997-05-13 | — | — | US | claimed |
| WO-1997002273-A1 | WARMING COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-23 | — | — | WO | claimed |
| EP-0721323-A1 | DIPHOSPHONIC ACID ESTERS AS TARTAR CONTROL AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 1996-07-17 | — | — | EP | claimed |
| EP-0719128-A1 | COMPOSITION CONTAINING PHOSPHATE DERIVATIVES | THE PROCTER & GAMBLE COMPANY (US) | 1996-07-03 | — | — | EP | claimed |
| EP-0719129-A1 | PYROPHOSPHATE DIESTERS FOR TARTAR CONTROL | THE PROCTER & GAMBLE COMPANY (US) | 1996-07-03 | — | — | EP | claimed |
| WO-1996015768-A1 | ORAL COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-05-30 | — | — | WO | claimed |
| WO-1995008979-A1 | DIPHOSPHONIC ACID ESTERS AS TARTAR CONTROL AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 1995-04-06 | — | — | WO | claimed |
| WO-1995007684-A1 | PYROPHOSPHATE DIESTERS FOR TARTAR CONTROL | THE PROCTER & GAMBLE COMPANY (US) | 1995-03-23 | — | — | WO | claimed |
| WO-1995007683-A1 | COMPOSITION CONTAINING PHOSPHATE DERIVATIVES | THE PROCTER & GAMBLE COMPANY (US) | 1995-03-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10688026-B2 | Buffered microencapsulated compositions and methods | LIPA, CHMP4B, APOB | ALDH1A1 3890/4885LMNA 492/4885TRPA1 2805/4885 |
| US-20210228691-A1 | Oral Care Compositions | LPO, LCT, MGAM | ALDH1A1 2586/4885LMNA 1203/4885TRPA1 4084/4885 |
| US-11185480-B2 | Buffered microencapsulated compositions and methods | CHMP4B, LIPA, APOB | ALDH1A1 3804/4885LMNA 930/4885TRPA1 4140/4885 |
| US-11648298-B2 | Oral care compositions | LPO, LCT, MGAM | ALDH1A1 2586/4885LMNA 1203/4885TRPA1 4084/4885 |
| US-10675227-B2 | Buffered microencapsulated compositions and methods | LIPA, CHMP4B, APOB | ALDH1A1 3541/4885LMNA 688/4885TRPA1 3273/4885 |
| US-11185479-B2 | Buffered microencapsulated compositions and methods | LIPA, CHMP4B, CRYAB | ALDH1A1 3594/4885LMNA 2057/4885TRPA1 2505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.